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Mouse  macrophages  (M~b) express  distinct  receptors  for  the  Fc  domain  of IgG 
(FcR), a trypsin-resistant FcR for IgG2b/IgG1, a trypsin-sensitive receptor for IgG2a, 
and a  third FcR for aggregated IgG3 (1, 2). In Mq~, the FcR can mediate antibody- 
dependent  endocytosis and cytolysis, trigger the respiratory burst  (RB), and control 
secretion of reactive intermediates  of oxygen, neutral proteinases, and prostaglandins 
(3-5). Mouse peritoneal M~b obtained after intraperitoneal infection with live bacillus- 
Calmette-Gu~rin  (BCG-PM)  express  characteristically  altered  properties  compared 
with  Mth  elicited  by a  sterile  inflammatory  agent,  thioglycollate  broth  (TPM),  or 
"resident"  Mt  h  from  untreated  animals  (RPM)  (6).  Only  BCG-PM  release  large 
amounts  of 1-1202 after  surface  stimulation,  kill  organisms  and  target  cells  more 
effectively, and are considered to be activated (7).  Mth activated with BCG and other 
agents express enhanced Ia antigen  (Ag), but reduced levels of a  M~b-specific Ag F4/ 
80 and of lectin-like  receptors  that  mediate  endocytosis of mannose-terminal  glyco- 
proteins (MFR)  (6, 8). BCG-PM also bind decreased levels of 2.4G2 a monoclonal rat 
anti-mouse  FcR  antibody  (Ab)  that  blocks  rosetting  of  IgG2b-  but  not  IgG2a- 
opsonized sheep erythrocytes (9). 
We show that  BCG infection enhances  expression  of the  Mth FcR for IgG2a, but 
not IgG2b. Isotype specificity of FcR can be reversed in nonactivated  M~b by BCG- 
induced  lymphokines,  and  IgG2a immune  complexes  are  more effective triggers  of 
the RB in activated Mq~. 
Materials  and Methods 
Media and Reagents.  Iscove's modified medium (IM), fetal bovine serum (FBS),  phosphate- 
buffered saline (PBS), and other reagents were obtained as described (6). 
Antibodies.  Ab  2.4G2  was  used  as  a  pure  protein  or  Fab  fragment  (a  gift  from  Dr.  J. 
Unkeless,  The Rockefeller University, New York).  Monoclonal anti-sheep erythrocyte (E)  Ab 
U88  (IgG2b)  and  UM-2  (IgG2a)  were  from  Dr.  B.  Diamond  (Albert  Einstein  College  of 
Medicine,  Bronx, NY)  (10).  Monoclonal anti-dinitrophenyl  (DNP)  Ab K3  (IgG2a) and K1 
(IgG2b) were from Dr. B. Askonas, Mill Hill, London, England and used as ascites or a protein 
purified by Dr. R. Dwek, University of Oxford. 
Peritoneal Cells.  RPM, TPM, and BCG-PM (6) were plated in 24- or 96-welt tissue  culture 
trays  (Linbro Chemical Co.,  Flow Laboratories,  Irvine,  Scotland),  or on glass  coverslips at 
1 ×  105 Mq~/well or 5 ×  105 Mdp/well, respectively. 
Lymphokine.  Lymphokine (8) was used at 5% vol/vol. 
Binding  of IgG.  Cells  were cultured  for 4  h-2  d  in  IM +  5%  FBS, washed  in  PBS, and 
cultured for 2 h in serum-free IM containing 0.05% lactalbumin hydrolysate for 2 h to allow 
dissociation or endocytosis of membrane-bound Ig. The medium was replaced by PBS  (11) 
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with a mixture of cold and trace-labeled IgG2aaDNP (2.5 X 104 cpm/ng) and IgG2baDNP (3 
X  10  a cpm/ng).  A  constant input of 12sI protein  was  used  in  all  wells.  After  30-90  min 
incubation  at 4°C, unbound Ig was rapidly removed by washing three times with ice-cold PBS. 
To determine surface-bound Ig, cells were dissolved  in 200/11 of 1 N NaOH and cell-associated 
radioactivity was measured. All assays were in duplicate, and variation from the mean usually 
did not exceed  10%. To determine whether ligand bound was at saturation, cells were incubated 
for 60 min with a constant amount of trace-labeled protein, excess cold protein was added, and 
radioactivity was measured after 5,  10, 15, 30, and 60 min. Background levels were reached by 
30 min. 
Binding and Phagocytosis of EIgG.  M~ on coverslips were placed in 0.5 ml IM in wells. 0.1 ml 
E coated with subagglutinating concentrations of monoclonal mouse anti-E IgG2a or Ig'G2b 
were  added. After 60 min at 4°C or 37°C, nonattached E were  removed, M~b fixed  in 0.5% 
glutaraldehyde in PBS, and attached E counted by phase contrast microscopy (12). 
Superoxide (0~)  release.  Linbro  wells  were  coated  with  gelatin-DNP  (13) by  overnight 
incubation at 45°C and incubated with saturating concentrations  of IgG2a or IgG2baDNP Ab 
for 30 min at 37°C, washed twice, and 0.45 ml of reaction mixture was added (14). 5 X 105 Mff 
purified on a  17% metrizamide gradient were added (50/d). Lymphokine-activated Mqb were 
assayed after 24 h treatment in T-25 tissue culture flasks (Falcon Labware, Oxnard, CA) coated 
with 1% gelatin to prevent adherence. Results were expressed  as nmol O)-/mg cell protein/60 
min. 
Results 
Binding of Monomeric and Complexed lgG Subclasses.  Adherent BCG-PM, TPM, and 
RPM, >90% pure, were incubated at 4°C with EIgG of different subclasses. Table I 
shows that binding of EIgG2a was enhanced on both BCG-PM and TPM, compared 
with  RPM  (Fig.  1 a,c)  (twofold  increase in EIgG2a bound/100 M~ and almost all 
M~b  labeled),  whereas  binding of EIgG2b  was  selectively decreased  on  BCG-PM. 
Ingestion of EIgG2a by BCG-PM was also increased, unlike uptake of EIgG2b, and 
experiments with opsonised 51Cr-labeled E  gave similar results (not shown). 
Unkeless and  Eisen  (11)  found  high  affinity binding of monomeric IgG2a  and 
IgG2b myeloma proteins to RPM, TPM, and the Mq~ cell line P388D1  and showed 
that the FcR for tgG2a was sensitive to trypsin. To study binding of monomeric IgG, 
M~b were incubated at 4°C with a2SI-labeled, uncomplexed monoclonal anti-DNP Ab 
of each subclass in the presence or absence of unlabeled Ig. The number of sites per 
cell was obtained by Scatchard analysis and specific binding at  saturation. Table I 
shows that assays of monomer binding and rosetting were in good agreement. BCG- 
PM showed a  70% increase in the number of IgG2a sites and a 30% decrease in IgG2b 
sites compared with  RPM,  whereas  both receptors were  increased on TPM.  There 
TASI~E I 
Binding of Monomeric and Complexed IgG Subclasses to Murine Peritoneal Mq~ 
EIg(}2a  ~2~I-IgG2a  ElgG2b  I25I-lg(}2b 
Targets  Percent  RBC/100  Percent  RBC/100 
M~b ro-  Mdp  Sites/M~b  Ka (M) -~  Mq~ ro-  M~b  Sites/M~b  Ka (M)  1 
setted  setted 
BCG-PM  95  665  110,000  2.2 X  108  68  360  65,000  4.0 X  107 
RPM  65  320  72,000  4.1  x  108  80  480  90,000  8.0 X  10  7 
TPM  86  602  120,000  3.1  X  10  s  94  720  200~{X)0  I 2 X  10  ~ 
* M+ were adhered  to glass coverslips in 24- or 96-well trays for 2 h  before assays of binding of complexed or nmnomeric 
lgG subclasses, respectively. Controls without  EIgG showed <lC~ binding. Binding to live M~ of monomeric l~I-labeled 
monoclonal  mouse anti-DNP ab was measured at 4°C for 60 min~ Binding to empty wells,  L  cell  fibroblasts,  or M~b in 
the presence of i00-fold  excess of unlabeled  myetoma protein  was <0.5% of input.  The number of sites determined  by 
Scatchard  analysis and by binding at saturation  were within 5% of values shown.  Results shown are representative of at 
least  three experiments. FIG.  1.  Rosetting assays for Mq~ FcR. (a)  BCG-PM bind EIgG2a.  (b) Modulation of IgG2a FcR. 
BCG-PM plated for 2 h on DNP-gelatin anti-DNP (IgG2a) complexes bind 30 E/100 M~ compared 
with 540 E/100 Mq~ plated on DNP-gelatin alone (a).  (c-f) Lymphokine (LK) selectively enhances 
expression of FcR  for IgG2a.  RPM  were treated with  5%  vol/vol LK for 24  h  before assay.  (c) 
RPM, EIgG2a;  (d) RPM +  LK, EIgG2a;  (e) RPM, EIgG2b;  (f)  RPM +  LK, EIgG2b. Monomer 
binding assays, in parallel, gave the following results: IgG2a -  RPM, 76,000 sites/cell, Ka 4.0 ×  l0  s 
M-I; RPM +  LK,  125,000  sites/cell, Ka 2.8 ×  l0  s M-~; IgG2b -  RPM 90,000 sites/cell, RPM + 
LK,  78,000  sites/cell,  Ka  not  done.  Experiments  shown  are  representative  of at  least  three 
independent assays. 
8O9 810  EZEKOWITZ ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE  II 
Effect of Immobilized Immune Complexes on Fc-mediated OF Production and on FcR Modulation 
Addition to DNP- 
gelatin coaled plate 
Superoxide release 
nmol O2/nag protein/60 rain produced by 
Modulation 
Percent BCG-PM with rosettes 
BCG-PM  RPM  RPM +  Lym-  TPM  ElgG2a  ElgG2b 
phokine 
None  160  12  40  26  92  60 
PMA (20 ng/well)  316  67  120  98  ND*  ND 
IgG2a anti-DNP  310  48  118  35  6  52 
IgG2b anti-DNP  225  64  55  42  54  12 
Assays of ():~ release  (>80%  inhibited by superoxide dismutase) were performed in duplicate. Results  representative of 
five independent experiments; variation from mean <10%. To modulate FcR, BCG-PM were cultivated on fixed immune 
complexes  and binding of EIgG2a and EIgG2b measured at 4°C for 45 rain. 
* Not done. 
was little change in affinity of each FcR on different Mff. The volume of elution of 
both  IgG  subclasses  on  Sephadex  G-200  indicated  that  the  proteins  used  were 
monomeric and the isoelectric focussing profiles confirmed the isotype specificity (Dr. 
T.  Rademacher, personal communication). Further evidence for subclass specificity 
was provided by competition experiments with other monoclonal Ab of the relevant 
subclasses (11).  Moreover, after treatment with 0.25% wt/vol trypsin at 37°C for 20 
min,  BCG-PM  no  longer  bound  IgG2a,  but  did  bind  both  IgG2b  and  the  Fab 
fragment of 2.4G2 (not shown). 
Role  of Lymphokines.  All changes characteristic of Mff activation can be shown to 
depend upon sensitized T  lymphocytes and specific Ag (8).  Fig.  1 (c-f) shows that 
addition of lymphokine to RPM for 24 h selectively enhances expression of the IgG2a 
FcR.  The  number  of EIgG2a  bound/100  M95  increased  from  140  to  620,  after 
lymphokine, whereas EIgG2b binding decreased from 480 to 360. Scatchard analysis 
of monomer binding (Fig. 1, legend) confirmed that lymphokine activation increased 
the number of IgG2a sites by 66%, whereas IgG2b sites decreased by 13%, with little 
change in affinity. Addition of lymphokine to P388D1  M~ and J774 induced a two- 
to threefold increase in the number of IgG2a sites/cell (not shown). 
Fc mediated OF Release and Modulation.  Secretion by phagocytic leukocytes of reduced 
products of oxygen can be triggered by phorbol myristate acetate (PMA)  (7) or by 
contact with Ab-coated particles or aggregated IgG.  Nathan  et al.  (3)  have shown 
that  2.4G2  inhibits  H202-dependent  antibody-dependent  cellular  cytotoxicity 
(ADCC) by BCG-PM mediated by heterogeneous mouse Ab. We examined the role 
of different IgG subclasses  in  triggering release of O~  by plating activated Mq~ on 
immobilized  DNP-anti-DNP  complexes.  Table  II  shows  that  both  BCG-PM  and 
lymphokine-activated  RPM  release  more  O~-  on  the  IgG2a  immune  complexes, 
comparable to that  triggered by PMA.  The high spontaneous release by BCG-PM 
plated directly on DNP-gelatin substrates is due to adherence and spreading, and is 
characteristic of BCG-activated M~ (G. Berton, unpublished observation). Nonacti- 
vated  M~  release  little O~-  on  immune  complexes, with  preference for the  IgG2b 
subclass.  We have concluded that  enhanced expression of IgG2a FcR by activated 
M~ correlates closely with its ability to mediate a secretory function. 
Michl  et  al.  (12)  have  shown  that  FcR  can  be  selectively modulated  from  the 
surface of Mq~ by cultivation on immobilized immune complexes. Support for distinct 
FcR on activated Me is provided by the evidence that the IgG2a and IgG2b receptors 
can be modulated independently. Fig.  1 b  and Table II show that  BCG-PM plated EZEKOWITZ ET AL.  BRIEF  DEFINITIVE REPORT  811 
on immune complexes of DNP-gelatin-anti-DNP  (IgG2a) exhibited a  95% reduction 
in  EIgG2a  rosettes,  compared  with  control  cells  on  DNP-gelatin  alone  (Fig.  1 a). 
Reciprocal experiments on IgG2b immune complexes and controls are shown in Table 
II. 
Discussion 
These studies establish that at least two of the Mq~ FcR specificities can be regulated 
independently. Mq~ activation in vivo or in vitro selectively enhances expression of the 
IgG2a FcR, whereas the IgG2b receptor is reduced, as shown by binding of monomer, 
complexed  Ab,  or  the  monoclonal  Ab,  2.4G2.  Our  studies  favor  the  notion  that 
monomer and aggregated IgG2a bind to the same FcR  (1), and independent  modu- 
lation of different FcR activities is compatible with the existence of two distinct  M~b 
FcR molecules (15).  Although  BCG infection could alter the M~b population  in the 
peritoneal cavity by recruitment, proliferation, and turnover, it is clear that receptor 
specificities  can  be  modulated  on  individual  M~.  Whereas  most  cells  in  all  the 
populations  studied  express  both  FcR  activities,  the  lymphokine  activated  RPM 
population  provides  a  stable,  closed  system  for analysis  and  clonal  cell  lines,  e.g., 
P388D 1 can be induced to show the same changes. 
The effects of BCG infection can  be contrasted  with  those evoked by an  inflam- 
matory stimulus such as thioglycollate broth, which does not induce Ia Ag or activate 
Mq~ cytotoxicity. Although the FcR for IgG2a was also increased in TPM, there was 
a concomitant increase of IgG2b expression. Reversed isotype specificity is not unique 
to BCG, since T~ypanosoma brucei infection another Mq~-activating stimulus (16) induces 
the  same  phenotype.  T  lymphocytes  and  lymphokines  are  thought  to  play  an 
important role in immune mechanisms of M~b activation, although the nature of the 
inducing  molecules  and  their  mechanism  of  action  remain  obscure.  Since  BCG 
infection  of  nude  mice  induces  the  same  FcR  phenotype  as  in  euthymic  mice 
(unpublished), T  cell-independent pathways could also activate Mq~. 
Surface expression of FcR for different isotypes correlates well with receptor activity 
in endocytosis and secretion ofO2. ADCC by BCG-PM takes place at the cell surface 
rather than intracellularly, and the FcR for IgG2b has been implicated in this process 
(3),  although  other workers  (17)  have shown  that  both IgG subclasses can  mediate 
cytolysis. Release of O~-  by BCG-PM is usually associated with  generation  of H202 
and enhanced killing activity. Our studies indicate that the IgG2a FcR could play a 
major role in cytotoxicity and account for the remarkable efficacy of the homologous 
Ab in mediating tumor destruction in vivo (18). 
Monoclonal, homologous Ab have revealed important differences in FcR structure 
and function which are inapparent with heterologous reagents. Since genes for the Ig 
isotypes  (19)  and  their receptors are regulated  with  a  considerable  degree of inde- 
pendence, the role of different FcR on M~b and lymphoid cells in immune processes 
merits further consideration. 
Summary 
After infection with bacillus Calmette-Gu~rin, peritoneal  macrophages  (M~b) dis- 
play enhanced expression of FcR for both monomeric and complexed IgG2a, but not 
IgG2b. Isotype specificity of FcR can be reversed on nonactivated  M~b by immune 
lymphokines, and IgG2a immune complexes are more effective triggers of the respi- 812  EZEKOWITZ ET AL.  BRIEF DEFINITIVE  REPORT 
ratory burst in activated MqS. Selective enhancement of Ig2a FcR by MdO activation 
could account for efficacy of homologous ab in mediating cytotoxicity in some systems. 
We thank Dr. J. C Unkeless and Dr. A. F. Williams for helpful discussions. 
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